NovoCure Limited Ordinary Shares NVCR
$16.95
-2.47%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (2 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $25.20
- Implied Upside
- +48.7%
- Price Target Range
- $17.00 – $52.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-24 | WedbushDavid Nierengarten |
Maintains | Neutral | $18 → $20 |
| 2026-07-23 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $46 → $52 |
| 2026-07-13 | JP MorganJessica Fye |
Reinstates | Neutral | $17 |
| 2026-06-18 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $48 → $46 |
| 2026-05-04 | Wells FargoLarry Biegelsen |
Maintains | Equal-weight | $14 → $17 |
| 2026-05-01 | Evercore ISI GroupVijay Kumar |
Maintains | Outperform | $16 → $20 |
| 2026-04-16 | WedbushDavid Nierengarten |
Reiterates | Neutral | $18 |
| 2026-02-26 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $47 → $49 |
| 2026-02-12 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $39 → $47 |
| 2026-01-15 | WedbushDavid Nierengarten |
Reiterates | Neutral | $18 |
| 2026-01-13 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $42 → $39 |
| 2025-10-30 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $38 → $42 |
| 2025-10-27 | JP MorganJessica Fye |
Maintains | Neutral | $25 → $23 |
| 2025-07-25 | Wells FargoLarry Biegelsen |
Downgrades | Overweight → Equal-weight | $40 → $15 |
| 2025-07-08 | Ladenburg ThalmannKevin DeGeeter |
Initiates coverage on | Buy | $30 |
| 2025-06-27 | Piper SandlerJason Bednar |
Reiterates | Overweight | $34 |
| 2025-04-23 | Piper SandlerJason Bednar |
Maintains | Overweight | $42 → $34 |
| 2025-04-16 | WedbushDavid Nierengarten |
Maintains | Neutral | $29 → $27 |
| 2025-04-10 | JP MorganJessica Fye |
Maintains | Neutral | $29 → $28 |
| 2025-01-14 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $38 |
| 2024-12-13 | Piper SandlerJason Bednar |
Maintains | Overweight | $28 → $42 |
| 2024-12-03 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $30 → $38 |
| 2024-12-02 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $30 → $38 |
| 2024-12-02 | Evercore ISI GroupVijay Kumar |
Upgrades | In-line → Outperform | $18 → $30 |
| 2024-11-21 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $30 |
| 2024-10-31 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $30 |
| 2024-10-16 | HC Wainwright & Co.Emily Bodnar |
Upgrades | Neutral → Buy | $24 → $30 |
| 2024-10-01 | Evercore ISI GroupVijay Kumar |
Maintains | In-line | $21 → $18 |
| 2024-07-26 | Wells FargoLarry Biegelsen |
Maintains | Overweight | $42 → $40 |
| 2024-07-26 | HC Wainwright & Co.Emily Bodnar |
Maintains | Neutral | $22 → $24 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $16.95
- Market Cap
- $2.05 billion
- 52-Week Range
- $9.82 – $21.45
- Average Volume
- 1.62 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.